XML 99 R88.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Computation of Diluted Loss Per Share Anti-dilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Merger Options [Member]    
Earnings Per Share [Abstract]    
Anti-dilutive securities [1] 4,966,666 5,666,666
Restricted Stock and Performance Stock Units [Member]    
Earnings Per Share [Abstract]    
Anti-dilutive securities [2] 6,965,415 1,059,432
Common Stock Warrants [Member]    
Earnings Per Share [Abstract]    
Anti-dilutive securities [3] 159,438,701 163,975,543
Series D Preferred Stock [Member]    
Earnings Per Share [Abstract]    
Anti-dilutive securities 1,196,337 1,196,337
Series F Preferred Stock [Member]    
Earnings Per Share [Abstract]    
Anti-dilutive securities [4] 103,478,261 155,481,366
[1] The Merger Options became exercisable upon the closing of the Bayswater Acquisition on March 26, 2025. Refer to Note 14 – Common Stock Options and Warrants for a discussion of the Merger Options.
[2] As of March 31, 2026 and 2025, all of the restricted stock and performance stock units presented were unvested. Refer to Note 15 – Long–Term Incentive Compensation for a discussion of the restricted stock units and performance stock units.
[3] Includes the maximum amount of Series F Preferred Stock Warrants as of March 31, 2026, which have not been issued as of March 31, 2026. Refer to Note 14 – Common Stock Options and Warrants for a discussion of the Series F Preferred Stock Warrants.
[4] Assumes the maximum number of converted shares using the Alternative Conversion at the NASDAQ minimum floor price, as defined in the Series F Certificate of Designation, as of March 31, 2026. Refer to Note 12 – Mezzanine Equity for a discussion of the Series F Preferred Stock.